Sepsis Spring2025 - Student
Course Outcomes
Infer the multidimensional impact of sepsis and infectious disorders on clients and their families (course outcome #1)
Correlate the pathophysiology, medical treatment, complications, and nursing interventions for sepsis and infectious disorders (course outcome #2)
Differentiate primary, secondary, and tertiary prevention measures for sepsis and infectious disorders (course outcome #2)
Prioritize nursing care for sepsis and infectious disorders to reduce risk potential (course outcome #2)
Design nursing care plans that incorporate pharmacological, dietary, lifestyle, and lifespan considerations (course outcome #2)
Differentiate signs and symptoms of sepsis and infectious disorders (course outcome #3)
Correlate abnormal assessment and diagnostic findings to priority nursing actions (course outcome #3)
Apply transmission-based precautions to care of clients with communicable infections (course outcome #4)
Sepsis Statistics
Leading cause of death in hospitalized patients
Annual deaths: 11 million
Annual cases: 47-50 million
Children affected: 40% of cases
Mortality rate: 25-50%
Sources: Sepsis Fact Sheet, 2020; Sepsis Awareness Campaign, 2010
Healthcare-Associated Sepsis
Sepsis acquired in healthcare settings is among the most frequent adverse events during care delivery worldwide.
Patient Assessment - qSOFA Criteria
Altered mental status, low blood pressure, fast respiratory rate
Definitions of Sepsis
CDC Definition: "The body’s overwhelming and life-threatening response to infection which can lead to tissue damage, organ failure, and death."
NIH Definition: "An illness in which the body has a severe response to bacteria or other germs."
Understanding Sepsis
Definition: Sepsis occurs when the body’s response to an infection injures its tissues and organs. Can lead to shock, organ failure, and death if not treated early.
Inflammatory mediators, interleukins, interferon, and histamine: Three weapons of mass destruction cause: vasodilation, capillary leakage “edema”, clotting blood
Stages of Sepsis
SIRS (Systemic Inflammatory Response Syndrome)
Sepsis
Severe Sepsis
Septic Shock
Detailed Stages of Sepsis
Stage 1: SIRS
Characterized by a severe inflammatory reaction.
Present if 2 or more of the following are observed:
Elevated Heart Rate >90
Abnormal Temperature <96.8 OR >101
Altered Respirations >20
Abnormal WBC Count < 4,000 OR >12,000
Stage 2: Sepsis
Positive for SIRS (2 of 4 criteria)
Known or suspected infection present.
Stage 3: Severe Sepsis
2 SIRS Criteria + known/suspected infection
Signs/symptoms indicating organ failure present. LABS
Stage 4: Septic Shock
2 SIRS Criteria + known/suspected infection + signs of organ failure
Persistent hypotension: SBP < 90 after fluid bolus indicates Severe Sepsis present. Urine output in an hr < 30cc/hr
Acute Organ Failure Indicators
Body Systems Affected:
Neurological
Confusion, Lethargy, Agitation
Cardiovascular
Increased HR, Decreased BP
Respiratory
Hypoxemia
Tachypnea
Hematologic
Clotting Issues
Leukocytosis or Leukopenia
Bleeding/Bruising
GI/Hepatic
Nausea/ Vomiting/ Diarrhea
Elevated Liver Function Tests
Ileus is a common complication in patients with sepsis, often leading to bowel obstruction and requiring careful management.
Renal
Decrease in Urine output <30/cc/hr
Elevated Creatinine
Integumentary
Decreased skin turgor
Cool and clammy/ Hot and flushed
Dry mucous membranes
Priority Assessments for Body Systems
Neurological System: Specific indicators needed.
Cardiovascular System: Specific indicators needed.
Respiratory System: Potential source of infection: Pneumonia.
Hematologic System: Specific indicators needed.
GI/Hepatic System: Potential sources of infection: Gastroenteritis, ischemic bowel.
Renal System: Potential sources: UTI, pyelonephritis.
Integumentary System: Potential sources: wounds, burns.
Significant Lab Findings
Identify relevant lab tests and ranges indicative of sepsis:
Lab test 1
Procalcitonin (Bacteria) >2= Sepsis / >10= Septic Shock
Lactate Level: >2 mmol/L indicates sepsis; >4 mmol/L suggests septic shock.
Lab test 2
Initial Treatment Bundles
Treatment within 3 hours:
Intervention 1
Start IV Fluid Resuscitation 30ml/kg crystalloid (NS, LR, Normosol)
1 liter in 60 men in gen care, 30 mins in ICU
Intervention 2
Labs- Lactate Acid Level (Check every 6 hours), Procalcitonin
Intervention 3
Blood cultures should be obtained prior to starting antibiotics to identify any underlying infections. 2 sets
Intervention 4
Broad Spectrum Antibiotics within 1 hour
Risk Factors for Sepsis
Specific risk factor
Hospital-acquired infections
Increase in invasive procedures and medical devices
CAUTI, Pneuomia
Specific risk factor
Increased number of antibiotic-resistant microorganisms
Specific risk factor
Emergency Surgeries
Malnutrition or immunosuppression
Specific risk factor
Chronic Illnesses (diabetes, hepatitis, CKD, and immunodefificency)
Increase in the older population.
Decreased physiologic reserves
aging immune system
Comorbidities
Nursing Interventions
Identify source of infection.
Collect specimens for culture and sensitivity.
Administer prescribed IV fluids and medications
Monitor Serum Levels (lactate,procalcitonin,WBC, coagulation Studies)
Additional interventions needed.
Monitor vital signs and intake and output.
Additional intervention needed.
Obtain provider of patient assess to evaluate the patient's condition and determine the necessity for further treatment options. ment
Case Study #1
Patient: 86-year-old female with new onset of weakness and fatigue. Vital signs:
HR: 92
Temp: 101.1°F
RR: 18
BP: 118/78
SPO2: 94% on Room Air
Assessment: Determine if SIRS, sepsis, severe sepsis, or septic shock is present.
Case Study #1 Continued
Diagnostics:
Chest x-ray: negative for acute disease
UA: Positive for UTI
WBC: 14.6
Lactic Acid: 2.6
Assessment: Determine presence of SIRS, sepsis, severe sepsis, or septic shock.
Infection Control and Prevention * KNOW MATRIX
Standard Precautions:
Used for all patients
Primary strategy for preventing Hospital Acquired Infections (HAIs)
Transmission-Based Precautions: For highly contagious microbes.
Categories: airborne, droplet, contact
Multi-Drug Resistant Organisms (MDRO)
Definitions:
Resistant to several drugs/medications, including:
Bacteria resistant to antibiotics
Viruses resistant to antivirals
Fungi resistant to antifungals
Over 2.8 million antibiotic-resistant infections occur in the U.S. annually, with over 35,000 deaths (CDC, 2019).
Common MDROs
Methicillin Resistant Staphylococcus aureus (MRSA)
Vancomycin Resistant Enterococcus (VRE)
Gram-negative bacteria producing extended spectrum beta-lactamase (ESBL)
Vancomycin Resistant Staphylococcus aureus (VRSA)
Carbapenem-resistant Enterobacteriaceae (CRE)
Carbapenemase-producing CRE (CP-CRE)
C. difficile Infection
Causes immense suffering and death, with 15,000 annual deaths attributed to the infection.
Approximately 500,000 illnesses occur in one year related to C. difficile.
Risk factors include:
Patients on antibiotics (7-10 times more likely)
Individuals in healthcare settings, especially hospitals or nursing homes
Over 80% of deaths occurred in individuals 65 and older.
Precautions for C. difficile
Enteric (Contact) Precautions
Strict contact measures are essential.
Airborne Precautions
Protocols for family and visitors for airborne precautions mentioned.